Cargando…

Exploring the Prominent and Concealed Inhibitory Features for Cytoplasmic Isoforms of Hsp90 Using QSAR Analysis

Cancer is a major life-threatening disease with a high mortality rate in many countries. Even though different therapies and options are available, patients generally prefer chemotherapy. However, serious side effects of anti-cancer drugs compel us to search for a safer drug. To achieve this target,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zaki, Magdi E. A., Al-Hussain, Sami A., Bukhari, Syed Nasir Abbas, Masand, Vijay H., Rathore, Mithilesh M., Thakur, Sumer D., Patil, Vaishali M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953649/ https://www.ncbi.nlm.nih.gov/pubmed/35337101 http://dx.doi.org/10.3390/ph15030303

Ejemplares similares

Perceiving the Concealed and Unreported Pharmacophoric Features of the 5-Hydroxytryptamine Receptor Using Balanced QSAR Analysis
por: Bukhari, Syed Nasir Abbas, et al.
Publicado: (2022)

Pharmacophore Synergism in Diverse Scaffold Clinches in Aurora Kinase B
por: Masand, Vijay H., et al.
Publicado: (2022)

QSAR, Molecular Docking, MD Simulation and MMGBSA Calculations Approaches to Recognize Concealed Pharmacophoric Features Requisite for the Optimization of ALK Tyrosine Kinase Inhibitors as Anticancer Leads
por: Jawarkar, Rahul D., et al.
Publicado: (2022)

QSAR and Pharmacophore Modeling of Nitrogen Heterocycles as Potent Human N-Myristoyltransferase (Hs-NMT) Inhibitors
por: Zaki, Magdi E. A., et al.
Publicado: (2021)

Mechanistic and Predictive QSAR Analysis of Diverse Molecules to Capture Salient and Hidden Pharmacophores for Anti-Thrombotic Activity
por: Zaki, Magdi E. A., et al.
Publicado: (2021)

Cytosolic Hsp90 Isoform-Specific Functions and Clinical Significance
por: Maiti, Samarpan, et al.
Publicado: (2022)

Identification of Isoform-Selective Ligands for the Middle Domain of Heat Shock Protein 90 (Hsp90)
por: Mak, Oi Wei, et al.
Publicado: (2019)

Identification of potent aldose reductase inhibitors as antidiabetic (Anti-hyperglycemic) agents using QSAR based virtual Screening, molecular Docking, MD simulation and MMGBSA approaches
por: Bakal, Ravindra L., et al.
Publicado: (2022)

The frantic play of the concealed HIV envelope cytoplasmic tail
por: da Silva, Eveline Santos, et al.
Publicado: (2013)

Mechanistic Analysis of Chemically Diverse Bromodomain-4 Inhibitors Using Balanced QSAR Analysis and Supported by X-ray Resolved Crystal Structures
por: Zaki, Magdi E. A., et al.
Publicado: (2022)

The Hsp90 isoforms from S. cerevisiae differ in structure, function and client range
por: Girstmair, Hannah, et al.
Publicado: (2019)

Characterization of HSP90 isoforms in transformed bovine leukocytes infected with Theileria annulata
por: Kinnaird, Jane H., et al.
Publicado: (2016)

A common conformationally coupled ATPase mechanism for yeast and human cytoplasmic HSP90s
por: Vaughan, Cara K, et al.
Publicado: (2009)

QSAR based virtual screening derived identification of a novel hit as a SARS CoV-229E 3CL(pro) Inhibitor: GA-MLR QSAR modeling supported by molecular Docking, molecular dynamics simulation and MMGBSA calculation approaches
por: Jawarkar, R.D., et al.
Publicado: (2022)

Structure-guided design of an Hsp90β N-terminal isoform-selective inhibitor
por: Khandelwal, Anuj, et al.
Publicado: (2018)

Isoform-selective Hsp90 inhibition rescues model of hereditary open-angle glaucoma
por: Stothert, Andrew R., et al.
Publicado: (2017)

Involvement of Yeast HSP90 Isoforms in Response to Stress and Cell Death Induced by Acetic Acid
por: Silva, Alexandra, et al.
Publicado: (2013)

Pan‐HSP90 ligand binding reveals isoform‐specific differences in plasticity and water networks
por: Stachowski, Timothy R., et al.
Publicado: (2023)

Identification of Anti-SARS-CoV-2 Compounds from Food Using QSAR-Based Virtual Screening, Molecular Docking, and Molecular Dynamics Simulation Analysis
por: Zaki, Magdi E. A., et al.
Publicado: (2021)

Circulating heat shock protein 90 (Hsp90) and autoantibodies to Hsp90 are increased in patients with atopic dermatitis
por: Sitko, Krzysztof, et al.
Publicado: (2021)

Y‐632 inhibits heat shock protein 90 (Hsp90) function by disrupting the interaction between Hsp90 and Hsp70/Hsp90 organizing protein, and exerts antitumor activity in vitro and in vivo
por: Wang, Wenqian, et al.
Publicado: (2016)

Prediction of new Hsp90 inhibitors based on 3,4-isoxazolediamide scaffold using QSAR study, molecular docking and molecular dynamic simulation
por: Abbasi, Maryam, et al.
Publicado: (2017)

Hsp-90 and the biology of nematodes
por: Him, Nik AIIN, et al.
Publicado: (2009)

Mechanisms of Hsp90 regulation
por: Prodromou, Chrisostomos
Publicado: (2016)

Regulatory Mechanisms of Hsp90
por: Prodromou, Chrisostomos
Publicado: (2017)

Inhibitors of HSP90 in melanoma
por: Mielczarek-Lewandowska, Aleksandra, et al.
Publicado: (2019)

Role of HSP90 in Cancer
por: Birbo, Bereket, et al.
Publicado: (2021)

Organismal Roles of Hsp90
por: van Oosten-Hawle, Patricija
Publicado: (2023)

The Distinct Assignments for Hsp90α and Hsp90β: More Than Skin Deep
por: Chang, Cheng, et al.
Publicado: (2023)

Structural Determination of Three Different Series of Compounds as Hsp90 Inhibitors Using 3D-QSAR Modeling, Molecular Docking and Molecular Dynamics Methods
por: Liu, Jianling, et al.
Publicado: (2011)

Traditional and Novel Mechanisms of Heat Shock Protein 90 (HSP90) Inhibition in Cancer Chemotherapy Including HSP90 Cleavage
por: Park, Sangkyu, et al.
Publicado: (2019)

A QSAR study on some series of antihepatitis B virus (HBV) agents
por: Arora, Preet K, et al.
Publicado: (2010)

HSP90 inhibitors disrupt a transient HSP90-HSF1 interaction and identify a noncanonical model of HSP90-mediated HSF1 regulation
por: Kijima, Toshiki, et al.
Publicado: (2018)

The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases
por: Lackie, Rachel E., et al.
Publicado: (2017)

QSAR Evaluations to Unravel the Structural Features in Lysine-Specific Histone Demethylase 1A Inhibitors for Novel Anticancer Lead Development Supported by Molecular Docking, MD Simulation and MMGBSA
por: Jawarkar, Rahul D., et al.
Publicado: (2022)

Targeting the Hsp90-Cdc37-client protein interaction to disrupt Hsp90 chaperone machinery
por: Li, Ting, et al.
Publicado: (2018)

Concealed index for concealed penis in prepubertal children
por: Ergashev, Kobiljon, et al.
Publicado: (2021)

Hsp40s Specify Functions of Hsp104 and Hsp90 Protein Chaperone Machines
por: Reidy, Michael, et al.
Publicado: (2014)

DAF-21/Hsp90 is required for C. elegans longevity by ensuring DAF-16/FOXO isoform A function
por: Somogyvári, Milán, et al.
Publicado: (2018)

Cytosolic Hsp90α and its mitochondrial isoform Trap1 are differentially required in a breast cancer model
por: Vartholomaiou, Evangelia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4e13fill003p0bdj7hoojkvfli